Atropine and Thrombophlebitis - a phase IV clinical study of FDA data

Summary:

Thrombophlebitis is reported as a side effect among people who take Atropine (atropine), especially for people who are male, 60+ old, also take Xanax, and have Colon cancer metastatic.

The phase IV clinical study analyzes which people have Thrombophlebitis when taking Atropine. It is created by eHealthMe based on reports of 8,649 people who have side effects when taking Atropine from the FDA, and is updated regularly.

What is Atropine?

Atropine has active ingredients of atropine. eHealthMe is studying from 8,693 Atropine users. Check the latest studies of Atropine.

What is Thrombophlebitis?

Thrombophlebitis (swelling (inflammation) of a vein caused by a blood clot) is found to be associated with 941 drugs and 1,267 conditions by eHealthMe. Check the latest studies of Thrombophlebitis.



On Jul, 10, 2026

8,649 people reported to have side effects when taking Atropine.
Among them, 12 people (0.14%) have Thrombophlebitis.

Could Atropine cause Thrombophlebitis?

Among these 12 people:

What is the gender of people who have Thrombophlebitis when taking Atropine? *

  • female: 8.33 %
  • male: 91.67 %

What is the age of people who have Thrombophlebitis when taking Atropine? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 8.33 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 8.33 %
  • 60+: 83.33 %

What are other drugs people take besides Atropine? *

  1. Xanax: 11 people, 91.67%
  2. Polaramine: 10 people, 83.33%
  3. Neurontin: 10 people, 83.33%
  4. Erbitux: 4 people, 33.33%
  5. Ondansetron: 3 people, 25.00%
  6. Dexamethasone: 3 people, 25.00%
  7. Oxazepam: 3 people, 25.00%
  8. Prednisone: 3 people, 25.00%
  9. Ranitidine Hydrochloride: 3 people, 25.00%
  10. Levaquin: 2 people, 16.67%

What are other side effects people have besides Thrombophlebitis? *

  1. Dyspnea (difficult or laboured breathing): 11 people, 91.67%
  2. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 11 people, 91.67%
  3. Pulmonary Embolism (blockage of the main artery of the lung): 10 people, 83.33%
  4. Drug Ineffective: 10 people, 83.33%
  5. Cellulitis (infection under the skin): 2 people, 16.67%
  6. Cardiomyopathy (weakening of the heart muscle): 1 person, 8.33%
  7. Diarrhea Haemorrhagic: 1 person, 8.33%
  8. Diarrhea: 1 person, 8.33%
  9. Diabetes Mellitus Inadequate Control: 1 person, 8.33%
  10. Depression: 1 person, 8.33%

What are the existing conditions these people have? *

  1. Colon Cancer Metastatic (cancer of colon spreads to other part of body): 10 people, 83.33%
  2. Cardiomyopathy (weakening of the heart muscle): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Atropine and have Thrombophlebitis?

- Check whether Thrombophlebitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Atropine:

Thrombophlebitis treatments and more:

How severe was Thrombophlebitis and when was it recovered:

Expand to all the drugs that have ingredients of atropine:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Atropine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Thrombophlebitis:

Browse all the conditions that are associated with Thrombophlebitis:


How the study uses the data?

The study uses data from the FDA. It is based on atropine (the active ingredients of Atropine) and Atropine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: